Advertisement
News
Subscribe to Surgical Products Magazine News
View Sample

FREE Email Newsletter

Surgical Products Daily

Safety Net Sought in Tumor Growth After Stem Cell Transplantation

August 6, 2014 12:09 pm | Comments

Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.

TOPICS:

New Standards Proposed for Reporting Spinal Cord Injury Experiments

August 6, 2014 11:44 am | Comments

The difficulty in replicating and directly comparing and confirming the scientific results reported by researchers worldwide who are studying new approaches to treating spinal cord injuries is slowing the translation of important new findings to patient care. A newly proposed reporting standard for spinal cord injury (SCI) experimentation defines the minimum information that is appropriate for modeling an SCI in the research setting.

TOPICS:

Childbirth Complications Vary Widely at U.S. Hospitals

August 5, 2014 11:41 am | Comments

 A study released on Monday reported that 13 percent of all women in the U.S. experience obstetrical complications. A University of Rochester-led study shows complication rates can vary as much as five-fold among hospitals, prompting researchers to call for the development of a national quality reporting system to improve maternal outcomes for more than 4 million women who give birth each year.

Advertisement

Bariatric Patients Exposed to Infections

August 5, 2014 11:24 am | Comments

Nearly 150 patients who underwent weight-loss surgery in Montreal were told they may have been exposed to HIV, hepatitis or other infections from an improperly cleaned medical instrument. According to CTV News, patients who underwent bariatric surgery between 2012 and 2014 at the Lachine Hospital in Montreal learned of the problem earlier this year.

Study: Hip Replacement Market Recovering

August 5, 2014 11:01 am | Comments

The hip replacement market is beginning to recover from the global recession and controversies surrounding metal-on-metal implants, with procedure volumes growing and patient confidence at an all-time high. According to GlobalData, approximately 1.7 million hip replacement procedures, including partial, primary, revision and resurfacing, were performed across the globe in 2013, and this figure is expected to increase to 2.5 million by 2020.

Stem Cell Scientist in Research Scandal Found Dead

August 5, 2014 10:48 am | Comments

Yoshiki Sasai, a senior Japanese scientist embroiled in a stem-cell research scandal died Tuesday in an apparent suicide, police said. Sasai, who supervised and co-authored stem-cell research papers that had to be retracted due to falsified contents, was found suffering from cardiac arrest at the government-affiliated science institute RIKEN in Kobe, in western Japan, according to Hyogo prefectural police.

Study provides look at future of transcranial ultrasound therapy

August 4, 2014 11:22 am | Comments

Research is taking place in transcranial ultrasound therapy, which in the future can potentially be applied to the treatment of brain tumours and targeted drug delivery. The therapy modality has already been successfully applied to the treatment of neuropathic pain disorder and essential tremors. The study focuses on two issues: skull-base heating and formation of standing-waves.

Once-conjoined twins celebrate 10 years of separation

August 4, 2014 10:24 am | Comments

The delicate separation 10 years ago of conjoined twins from the Philippines wasn't perfect, but the boys' mother says their very survival is reason enough to celebrate the anniversary. The boys were separated on Aug. 4, 2004, in an operation that climaxed a then-unusual "staged separation" that took four surgeries over nine months.

Advertisement

Group Finds Excellent Clinical Results and Expanded Enrollment in OCCLUDE I Study

July 31, 2014 4:19 pm | Comments

ArtVentive Medical Group announced excellent clinical results in conjunction with expanded enrollment in the ArtVentive Endoluminal Occlusion System, OCCLUDE I post-market surveillance study. In conjunction with the study, four female patients were treated for pelvic congestion syndrome and seven male patients were treated for varicoceles using the ArtVentive EOS™ device.

Kala Pharmaceuticals Initiates Phase 2 Trial

July 31, 2014 3:57 pm | Comments

“We are excited about the progress of our lead nanotechnology-based program, LE-MPP, with four active clinical trials,” said Kim Brazzell, Ph.D., Chief Medical Officer of Kala. “With the initiation of our latest trial in RVO and DME, Kala is making significant progress toward demonstrating the unique ability of Kala’s MPP platform to deliver drugs to the back of the eye following topical administration.”

BioTime Expands Clinical Development Of Bladder Cancer Diagnostic

July 31, 2014 3:40 pm | Comments

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation announced that OncoCyte has expanded the clinical development of its urine-based bladder cancer diagnostic test by initiating a multi-site clinical trial. OncoCyte’s initial clinical study of its bladder cancer diagnostic test began in January and involves pathology specimens being collected at a leading medical institution with a reputation for excellence and discovery.

American CareSource Secures $5 Million Line of Credit

July 31, 2014 3:13 pm | Comments

American CareSource Holdings a leading national network of ancillary health care providers and operator of urgent care centers, has closed on a $5 million line of credit with a top-tier U.S. bank, giving the it funding to continue its strategy of acquiring urgent care centers. “The credit facility offers us financial flexibility at a very attractive interest rate," said Dr. Richard W. Turner, Chairman of the Board and CEO.

Women Could Benefit From Tamoxifen Therapy For Breast Cancer

July 31, 2014 2:00 pm | Comments

Innovative research has identified a gene signature that has potential to identify which patients will benefit from tamoxifen therapy. Tamoxifen is an endocrine therapy that is one of the most frequently used medications worldwide to treat breast cancer after surgery. However, even among those patients for whom tamoxifen is effective at reducing recurrence risk, many of them experience menopausal-like side effects.

Active O Kicks Off New Clinical Trial Studying Non-Surgical Treatment For Lower Back Pain

July 31, 2014 1:47 pm | Comments

A clinical trial being conducted at several high-profile centers in Canada has begun recruiting patients to investigate a new, non-surgical treatment for lower back pain caused by a contained herniated disc. The trial is studying a minimally invasive injection of natural gases designed to dissolve a small amount of disc tissue in order to resolve the disc herniation.

Eighty Percent Of Aortic Stenosis Patients Report Same/Better Health 1 Year After Treatment

July 31, 2014 1:01 pm | Comments

A survey of 13,860 patients who had undergone interventions for aortic valve disease has revealed that over 80 percent were in the same or a better state of health one year after the intervention. Aortic stenosis is the most frequent valvular heart disease in the aging Western population, and the prognosis of this disease in symptomatic patients with conservative therapy is poor.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading